Aidarex Ferrous Sulfate Tablets Recall: Foreign Tablets Risk
Aidarex Pharmaceuticals recalls Ferrous Sulfate 325mg tablets with foreign tablets/capsules. Check batch numbers 57909-1 (exp 04/30/2019) and 57909-2 (exp 06/30/2019) for affected units.
Recall notice
Presence of Foreign Tablets/Capsules
Contact the company
What happened, in plain English
Aidarex Pharmaceuticals is recalling Ferrous Sulfate 325mg tablets that may contain foreign tablets or capsules. This could lead to unintended ingestion of harmful substances if the product is taken without proper identification. Read more at govinfonow.com/recall/40623-aidarex-ferrous-sulfate-tablets-recall-foreign-tablets-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/40623-aidarex-ferrous-sulfate-tablets-recall-foreign-tablets-risk · Updated October 7, 2026 · FDA enforcement record: FDA #D-0810-2018
Cite this page
“Aidarex Ferrous Sulfate Tablets Recall: Foreign Tablets Risk.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40623-aidarex-ferrous-sulfate-tablets-recall-foreign-tablets-risk. Based on FDA recall #D-0810-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0810-2018%22&limit=1).
Why it’s dangerous
Foreign tablets or capsules in the product could be ingested by users, potentially causing harm from unintended substances. The presence of these foreign items may lead to incorrect dosing or ingestion of harmful materials.
Who’s affected
People who own or use Ferrous Sulfate 325mg tablets with batch numbers 57909-1 (expiring April 30, 2019) or 57909-2 (expiring June 30, 2019) are affected. Those taking iron supplements for anemia are most at risk.
How to tell if you have this one
Check the batch number on the product packaging. Affected units have batch ID 57909-1 (expiring April 30, 2019) or 57909-2 (expiring June 30, 2019).
- Brand
Aidarex Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Batch
Look for batch numbers 57909-1 (expiring April 30, 2019) or 57909-2 (expiring June 30, 2019) on the packaging.
Where it went and when
Where it was distributed
Distributed in Florida.
FDA distribution: “Product was distributed to Florida” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Florida.
Recall timeline
FDA terminated this recall 20 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0810-2018 (April 10, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0810-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.